Stoke Therapeutics Inc (STOK)
NASDAQ:STOK
Holding STOK?
Track your performance easily

Stoke Therapeutics (STOK) Financial Statements

338 Followers

Stoke Therapeutics Financial Overview

Stoke Therapeutics's market cap is currently ―. The company's EPS TTM is $-2.185; its P/E ratio is -6.74; Stoke Therapeutics is scheduled to report earnings on November 13, 2024, and the estimated EPS forecast is $-0.54. See an overview of income statement, balance sheet, and cash flow financials.
Jun 24Mar 24Dec 23Sep 23Jun 23
Income Statement-
Total Revenue$ 4.83M$ 4.22M$ 2.80M$ 3.31M$ -2.48M
Gross Profit$ 4.83M$ 4.22M$ 2.80M$ 3.31M$ -2.48M
EBIT$ -25.70M$ -26.37M$ -26.96M$ -24.54M$ -30.65M
EBITDA$ -25.44M$ -25.84M$ -26.39M-$ -30.19M
Net Income Common Stockholders$ -25.70M$ -26.37M$ -26.96M$ -24.54M$ -30.65M
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments$ 281.98M$ 178.58M$ 201.39M$ 214.72M$ 231.45M
Total Assets$ 307.76M$ 205.18M$ 228.34M$ 239.89M$ 256.92M
Total Debt$ 0.00$ 0.00$ 0.00$ 0.00$ 0.00
Net Debt$ -281.98M$ -178.58M$ -201.39M$ -214.72M$ -231.45M
Total Liabilities$ 65.05M$ 64.84M$ 68.78M$ 66.89M$ 66.72M
Stockholders Equity$ 242.71M$ 140.34M$ 159.56M$ 173.00M$ 190.19M
Cash Flow-
Free Cash Flow$ -17.52M$ -24.58M$ -20.88M-$ -22.64M
Operating Cash Flow$ -17.48M$ -24.57M$ -20.65M$ -17.26M$ -21.80M
Investing Cash Flow$ -88.28M$ 9.99M$ 14.77M$ 14.62M$ 23.47M
Financing Cash Flow$ 120.65M$ 1.72M$ 7.34M$ 562.00K$ 48.00K
Currency in USD

Stoke Therapeutics Earnings and Revenue History

Stoke Therapeutics Debt to Assets

Stoke Therapeutics Cash Flow

Stoke Therapeutics Forecast EPS vs Actual EPS

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis